Kymriah medication
Ended Awarded Last action
- Contract number
- 36C25721N0069
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $283,527
Award facts
- Contract value 100% obligated
- $283,526.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lake Mary, FL 32746, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $283,527 |
About this award
This federal contract award is for the delivery of the Kymriah cancer medication to the U.S. Department of Veterans Affairs (VA). The prime contractor is Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical products.
The contract, awarded by the Veterans Integrated Service Network 17 (VISN 17) of the VA, is a Blanket Purchase Agreement (BPA) call against Novartis' Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs (FSS-61-IB). The contract has a ceiling value of $283,526.57 and a period of performance through October 16, 2021. There was no set-aside designation for this award. Novartis previously received over $2.8 million in orders for Kymriah from various VA networks and the VA National Acquisition Center, as well as a $21.5 million BPA to continue ordering the medication through September 2024.
Quick answers
Who was awarded contract 36C25721N0069?
36C25721N0069 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 17 (Veterans Health Administration) on October 16, 2020.
How much is contract 36C25721N0069 worth?
The government has obligated $283,527 on 36C25721N0069.
Is contract 36C25721N0069 an order under another contract?
Yes. 36C25721N0069 is a BPA call under 36F79720D0180-36E79720A0019, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25721N0069 competed?
The extent of competition for 36C25721N0069 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award